Evidence map›Paper›PMID 36517926›Full record

ArticleAddiction science & clinical practice2022

Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care.

Treah Haggerty, Nicholas A Turiano, Tyra Turner, Patricia Dekeseredy, Cara L Sedney

Open access · goldAbstract read
In one paragraph

Article in Addiction science & clinical practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Treah HaggertyDepartment of Family Medicine, West Virginia University, 2nd Floor HSS, Morgantown, WV, 26506, USA. haggertyt@hsc.wvu.edu.ORCID 0000-0001-8327-686X
Nicholas A TurianoDepartment of Psychology, West Virginia Prevention Research Center, West Virginia University, Morgantown, WV, 26506, USA.
Tyra TurnerHealth Sciences, West Virginia University, Morgantown, WV, 26506, USA.
Patricia DekeseredyDepartment of Neurosurgery, West Virginia University, Morgantown, WV, 26506, USA.
Cara L SedneyDepartment of Neurosurgery, West Virginia University, Morgantown, WV, 26506, USA.
West Virginia University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI JUDITH FEINBERG · 2012 to 2026
$81.0M
West Virginia Prevention Research CenterU48DP006391 · DP · WEST VIRGINIA UNIVERSITY · PI DINO, GERI A, MANN, MICHAEL J · 2018 to 2023
$4.2M
NCCDPHP CDC HHS U48 DP006391NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

backgroundMedication for opioid use disorder (MOUD) includes administering medications such as buprenorphine or methadone, often with mental health services. MOUD has been shown to significantly improve outcomes and success of recovery from opioid use disorder. In WV, only 18% of providers including physicians, physician assistants, and nurse practitioners are waivered, and 44% of non-waivered providers were not interested in free training even if compensated. This exploratory research seeks to understand intervention-related stigma in community-based primary care providers in rural West Virginia, determine whether financial incentives for training may be linked to levels of stigma, and what level of financial incentives would be required for non-adopters of MOUD services provision to obtain training.

methodSurvey questions were included in the West Virginia Practice-Based Research Network (WVPBRN) annual Collective Outreach & Research Engagement (CORE) Survey and delivered electronically to each practice site in WV. General demographic, staff attitudes and views on compensation for immersion training for delivering MOUD therapy in primary care offices were returned. Statistical analysis included logistic and multinomial logistic regression and an independent samples t-test.

resultsData were collected from 102 participants. Perceived stigma did significantly predict having a waiver with every 1-unit increase in stigma being associated with a 65% decreased odds of possessing a waiver for buprenorphine/MOUD (OR = 0.35; 95% CI  0.16-0.78, p = 0.01). Further, t-test analyses suggested there was a statistically significant mean difference in perceived stigma (t(100) = 2.78, p = 0.006) with those possessing a waiver (M = 1.56; SD = 0.51) having a significantly lower perceived stigma than those without a waiver (M = 1.92; SD = 0.57). There was no statistically significant association of stigma on whether someone with a waiver actually prescribed MOUD or not (OR = 0.28; 95% CI  0.04-2.27, p = 0.234).

conclusionThis survey of rural primary care providers demonstrates that stigmatizing beliefs related to MOUD impact the desired financial incentive to complete a one-day immersion, and that currently unwaivered providers endorse more stigmatizing beliefs about MOUD when compared to currently waivered providers. Furthermore, providers who endorse stigmatizing beliefs with respect to MOUD require higher levels of compensation to consider such training.

Indexed as

BuprenorphineOpioid-Related DisordersAnalgesics, OpioidHumansMethadoneMotivationOpiate Substitution TreatmentPrimary Health CareAnalgesics, OpioidBuprenorphineMethadoneMOUDOpioidOpioid treatment providerOpioid use disorderRuralTraining

Identifiers

PMID36517926
PMCPMC9749153
OpenAlexW4311495018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.